Navigation Links
COPD Tops Asthma as the Focus Indication for Next Generation Respiratory Therapies at the 2012 American Thoracic Society Conference
Date:5/31/2012

y in advance of the registration of the associated FDC product."

Despite the notable omission of pivotal RELOVAIR trial data from this year's ATS proceedings, GSK and Theravance continue to be the trailblazers in the race to launch the next generation COPD therapy through their partnership in two key FDC programs, RELOVAIR (fluticasone furoate+vilanterol) and their LAMA/LABA combination ('719+vilanterol). With the patent expiry of Advair in 2011 and the looming expiration of Symbicort later this year, GSK has positioned itself as the front runner in capturing a large share of the future respiratory market with these two strong Phase III FDC drug programs and plans to submit regulatory RELOVAIR applications for COPD in the US and Europe in mid-2012.  However, several competitors are riding on their heels, including Boehringer Ingelheim, Novartis, Almirall/Forest, and the up-and-coming Pearl Therapeutics, with strong FDC candidates in their pipelines.

"Pearl Therapeutics is only in planning stages for their Phase III FDC program and is certainly the underdog among the current competition, but their innovative PT003 product had stellar Phase II data at ATS and they announced plans for PT010, a triple combination therapy of LAMA (glycopyrrolate), LABA (formoterol fumarate), and an inhaled corticosteroid, in one of their presentations," comments Ms. Stacey. "They will be an exciting company to watch as competitors in the FDC respiratory market race cross the finish line for novel inhaled therapies in COPD."

About Citeline
Citeline (www.citeline.com)  provides the world's most comprehensive real-time R&D intelligence to the pharmaceutical industry, covering global clinical trial, investigator and drug intelligence. Our data is drawn from over 20,000 unique sources and analyzed by the industry's largest team – over 250 full-time expert analysts and editors.

Media Invitati
'/>"/>

SOURCE Citeline
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Phase 2a Multi-Dose Study Initiated by MedImmune in Patients With Asthma to Further Expand Anti-Interleukin-9 Program
2. MedImmune Initiates Phase 2a Multi-Dose Study in Patients with Asthma
3. Study Shows Need to Test More COPD and Asthma Patients for Underdiagnosed Pulmonary Disease
4. The New England Journal of Medicine Publishes First Clinical Results for MedImmunes Chitinase-like Protein YKL-40 in Patients With Asthma
5. Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer
6. GlaxoSmithKline and Theravance Announce Start of Large Phase 2B ICS and LABA Studies for Asthma in the Horizon Program
7. Inverseon Announces Positive Phase IIa Asthma Study
8. Study Compares Bronchodilatory Effects of SYMBICORT(R) and Advair in Adults With Asthma
9. MedImmune Advances Clinical Development of Antibody Targeting Interleukin-9 in Patients with Asthma
10. Genaera Announces MedImmune Initiation of Phase 2a Trial of Antibody Targeting Interleukin-9 in Patients with Asthma
11. MAP Pharmaceuticals Reports Positive Results From Comparative Pharmacokinetic Trial for its Pediatric Asthma Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... 2014 /PRNewswire-iReach/ -- VAPETEK™, Inc. has announced a ... use in portable vaporizers, which contains CBD, or ... cannabis, cannabidiol offers consumers a THC-free product made ... vaporizer technology. Photo - http://photos.prnewswire.com/prnh/20140711/126344 ... different compounds which are currently known, two of ...
(Date:7/11/2014)... HILL, N.C. , July 11, 2014 /PRNewswire/ ... of pharmaceutical marketing and, consequently, organizations are turning ... for patients. As part of this ... it,s important to educate, communicate and engage patients ... disease awareness to patient empowerment. By mapping the ...
(Date:7/11/2014)... CHAPEL HILL, N.C. , July 11, 2014 ... research analysis approaches are evolving across industry sectors ... are now examining better ways to engage with ... how consumers inform themselves and make critical purchasing ... by benchmarking firm, Best Practices, LLC, one area ...
Breaking Medicine Technology:VAPETEK Releases CBD-Infused eLiquid For The Consumer Market 2New Study Uses Six-Step Patient Journey as Framework for Consumer-Focused Marketing Opportunities 2New Technologies Transforming Consumer Marketing Research Playbook 2
... Mass., March 18, 2011 Cytel ... implementation services and software, proudly announced today the ... Baker as Vice President, Clinical Research Services. ... demonstrated biopharmaceutical development leadership at some of the ...
... family of Midland, Michigan have a new lease on ... and Mike ALL underwent Roux-en-Y bariatric surgery ... to offer this life-changing surgery. The surgeries were performed ... The family has lost 445 pounds, and counting. ...
Cached Medicine Technology:Cytel Hires Biopharmaceutical Development Veteran Jim Baker to Support Expansion of its Clinical Research Offerings 2Midland Family Undergoes Bariatric Surgery at Hurley Medical Center--Loses 445 Pounds & Counting—Tells their Life-Saving Story to Media on March 18, 2011 2
(Date:7/13/2014)... According to the Living With KP book ... guide that features a series of tips and advice ... pilaris). This guide consists of 14 chapters including:, ...     Chapter 2: What Cause KP? ,     Chapter ... ,     Chapter 4: Keratosis Pilaris Treatment , ...
(Date:7/12/2014)... The Chicken Egg Production ... years, buoyed by stable demand for industry products as ... are a relatively affordable staple for most families across ... grows in line with the size of the population,” ... for new specialty egg products with enriched qualities, such ...
(Date:7/12/2014)... HealthDay Reporter SATURDAY, July 12, 2014 (HealthDay ... technique used to grind up uterine growths and remove them ... to other parts of a woman,s body, U.S. health advisers ... Drug Administration also said that women who do undergo the ... written consent stating that they understand the potential risks, the ...
(Date:7/12/2014)... fastest-growing mobile technology is LTE (Long Term Evolution). The ... to grow due to the rapid evolution of LTE. ... traffic, which is a major driver for the Communications ... equipment comply with industry standards, and services which meet ... is estimated to grown from $3.75 billion in 2013 ...
(Date:7/12/2014)... Pittsburgh, PA (PRWEB) July 12, 2014 "The ... so it’s uncomfortable and painful to wear shoes," said an ... a special sock that prevents this from happening. , He ... an effective way to prevent the second and big toes ... more endurance while wearing shoes. Ergonomic and easy to use, ...
Breaking Medicine News(10 mins):Health News:Living With KP Book Review Exposes Jennifer Richards' Keratosis Pilaris Guide – Vkool.com 2Health News:Living With KP Book Review Exposes Jennifer Richards' Keratosis Pilaris Guide – Vkool.com 3Health News:Chicken Egg Production in Canada Industry Market Research Report Now Available from IBISWorld 2Health News:Chicken Egg Production in Canada Industry Market Research Report Now Available from IBISWorld 3Health News:FDA Advisers Weigh Risks of Procedure for Removal of Uterine Fibroids 2Health News:FDA Advisers Weigh Risks of Procedure for Removal of Uterine Fibroids 3Health News:North America Communication Test and Measurement (CT&M) Market Worth $1.9 Billion by 2018 - New Report by MicroMarket Monitor 2Health News:North America Communication Test and Measurement (CT&M) Market Worth $1.9 Billion by 2018 - New Report by MicroMarket Monitor 3Health News:North America Communication Test and Measurement (CT&M) Market Worth $1.9 Billion by 2018 - New Report by MicroMarket Monitor 4Health News:North America Communication Test and Measurement (CT&M) Market Worth $1.9 Billion by 2018 - New Report by MicroMarket Monitor 5
... ... Conference Scholarship Writing Contest , ... Green Bay, WI (Vocus) - Undergraduate nursing students have an opportunity of a lifetime: ... an international nursing conference in Madrid, Spain. , , , , ,The article writing ...
... , , Alarming comments by ... , , WASHINGTON, Sept. 17 Later today, ... AIDS Coordinator. "While we welcome Ambassador Goosby to his new ... range of issues that affect the health and well-being of the ...
... , , , ... Centre and ActionAid International USA both receive funding to help ... , , NORTH WEST FRONTIER PROVINCE, ... granted over US$65,000 to provide food, medication, cattle and livestock ...
... BETHPAGE, N.Y., Sept. 17 The Lustgarten Foundation, the ... treatment of pancreatic cancer, today issued the following statement on ... Brand. , , Kerri Kaplan, Lustgarten ... sincere condolences to Mr. Brand,s family and the entire NCAA ...
... , BATESVILLE, Ind., Sept. 17 The Board ... plans to facilitate the orderly succession and retirement of Peter H. Soderberg, president ... arrival in 2006 and endorsed by the Board at that time, Soderberg will ... 2011 (at age 65). , , The Board ...
... SEATTLE, Sept. 17 National science and engineering company Integral ... Mr. Sean Kosinski to its geochemistry and hydrogeology team. With ... increasing demand for specialized technical expertise to support mine permitting, ... "Integral is pleased to have such excellent people join our ...
Cached Medicine News:Health News:Write your Ticket to Madrid, Spain! 2Health News:Write your Ticket to Madrid, Spain! 3Health News:Are Obama Administration Policies Undermining Global AIDS and Health Responses? 2Health News:Are Obama Administration Policies Undermining Global AIDS and Health Responses? 3Health News:The Prem Rawat Foundation Makes Two Grants to Provide Relief in Pakistan 2Health News:Hill-Rom Announces CEO Succession Plan 2Health News:Hill-Rom Announces CEO Succession Plan 3Health News:Hill-Rom Announces CEO Succession Plan 4Health News:New Hires Signal Continued Expansion of Integral Consulting's Geochemistry, Hydrogeology, and Mining Capabilities 2
... Series I Instrument program offers state-of-the-art quality ... while maintaining strength and durability. Low profile ... tight joint spaces. Series I instruments are ... style, size and angle required for large ...
... offers state-of-the-art quality in an instrument of ... durability. Low profile cutting tips allow access ... I instruments are available in just about ... required for large and small joint arthroscopic ...
... Instrument program offers state-of-the-art quality in an ... strength and durability. Low profile cutting tips ... spaces. Series I instruments are available in ... and angle required for large and small ...
... The Series I Instrument program offers ... low profile, while maintaining strength and durability. ... pathology in tight joint spaces. Series I ... cutting tip style, size and angle required ...
Medicine Products: